舒张功能障碍的治疗策略：临床视角
Therapeutic strategies for diastolic dysfunction: a clinical perspective.
作者信息
Ha Jong-Won, Oh Jae K
机构信息
Division of Cardiology, Yonsei University College of Medicine, Seoul, Korea.
出版信息
J Cardiovasc Ultrasound. 2009 Sep;17(3):86-95. doi: 10.4250/jcu.2009.17.3.86. Epub 2009 Sep 30.
Abstract
Diastolic dysfunction, which is increasingly viewed as being influential in precipitating heart failure and determining prognosis, is often unrecognized and has therapeutic implications distinct from those that occur with systolic dysfunction. In this review, several therapeutic modalities including pharmacologic, nonpharmacologic, and surgical approaches for primary diastolic dysfunction and heart failure will be discussed.
摘要
舒张功能障碍越来越被认为在引发心力衰竭和决定预后方面具有重要影响，但其常常未被识别，并且具有与收缩功能障碍不同的治疗意义。在本综述中，将讨论包括药物、非药物和手术方法在内的几种针对原发性舒张功能障碍和心力衰竭的治疗方式。
相似文献
1
Therapeutic strategies for diastolic dysfunction: a clinical perspective.
J Cardiovasc Ultrasound. 2009 Sep;17(3):86-95. doi: 10.4250/jcu.2009.17.3.86. Epub 2009 Sep 30.
2
Assessing Diastolic Function as an Important Tool for Clinical Decision-making in Critically Ill Patients.
J Cardiovasc Imaging. 2020 Jul;28(3):165-173. doi: 10.4250/jcvi.2020.0042. Epub 2020 May 27.
3
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Dan Med Bull. 2001 Nov;48(4):199-210.
4
[Heart failure due to diastolic dysfunction: the treatment principles].
Ital Heart J Suppl. 2000 Apr;1(4):469-80.
5
Prognosis in heart failure: is systolic or diastolic dysfunction more important?
Herz. 1991 Sep;16 Spec No 1:324-9.
6
["Severe" congestive heart failure at a medical center].
Rev Port Cardiol. 1993 Nov;12(11):919-30, 900.
7
Primary diastolic heart failure.
Am J Geriatr Cardiol. 2002 May-Jun;11(3):178-87; quiz 188-9. doi: 10.1111/j.1076-7460.2002.00051.x.
8
Diagnosis and management of diastolic dysfunction and heart failure.
Am Fam Physician. 2006 Mar 1;73(5):841-6.
9
Combined right ventricular systolic and diastolic dysfunction represents a strong determinant of poor prognosis in patients with symptomatic heart failure.
Int J Cardiol. 2005 Nov 2;105(2):164-73. doi: 10.1016/j.ijcard.2004.12.031.
10
Genetics of systolic and diastolic heart failure.
J Hypertens. 2015 Jan;33(1):3-13. doi: 10.1097/HJH.0000000000000400.
引用本文的文献
1
Prognostic impact of beta-blocker use by N-terminal pro-brain natriuretic peptide level in acute heart failure patients.
ESC Heart Fail. 2024 Dec;11(6):3842-3853. doi: 10.1002/ehf2.14974. Epub 2024 Jul 17.
2
Can left atrial diameter measured by computed tomography predict the presence and degree of left ventricular diastolic dysfunction?
Clin Exp Emerg Med. 2024 Dec;11(4):358-364. doi: 10.15441/ceem.24.194. Epub 2024 May 23.
3
Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older patients with heart failure and preserved ejection fraction.
Int J Cardiol Cardiovasc Risk Prev. 2023 Jul 28;18:200201. doi: 10.1016/j.ijcrp.2023.200201. eCollection 2023 Sep.
4
Color M-Mode Echocardiography for Non-Invasive Assessment of the Intraventricular Pressure in Dogs Before and After Ductus Arteriosus Occlusion: A Retrospective Study.
Front Vet Sci. 2022 Jul 12;9:908829. doi: 10.3389/fvets.2022.908829. eCollection 2022.
5
Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.
Int J Hepatol. 2021 Dec 2;2021:5592376. doi: 10.1155/2021/5592376. eCollection 2021.
6
Personalized intervention cardiology with transcatheter aortic valve replacement made possible with a non-invasive monitoring and diagnostic framework.
Sci Rep. 2021 May 25;11(1):10888. doi: 10.1038/s41598-021-85500-2.
7
MK2-Deficient Mice Are Bradycardic and Display Delayed Hypertrophic Remodeling in Response to a Chronic Increase in Afterload.
J Am Heart Assoc. 2021 Feb 16;10(4):e017791. doi: 10.1161/JAHA.120.017791. Epub 2021 Feb 3.
8
Assessing Diastolic Function as an Important Tool for Clinical Decision-making in Critically Ill Patients.
J Cardiovasc Imaging. 2020 Jul;28(3):165-173. doi: 10.4250/jcvi.2020.0042. Epub 2020 May 27.
9
The evolutionarily conserved C-terminal peptide of troponin I is an independently configured regulatory structure to function as a myofilament Ca-desensitizer.
J Mol Cell Cardiol. 2019 Nov;136:42-52. doi: 10.1016/j.yjmcc.2019.09.002. Epub 2019 Sep 7.
10
Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis.
Clin Mol Hepatol. 2018 Dec;24(4):409-416. doi: 10.3350/cmh.2018.0034. Epub 2018 Aug 27.
本文引用的文献
1
Irbesartan in patients with heart failure and preserved ejection fraction.
N Engl J Med. 2008 Dec 4;359(23):2456-67. doi: 10.1056/NEJMoa0805450. Epub 2008 Nov 11.
2
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
Lancet. 2003 Sep 6;362(9386):777-81. doi: 10.1016/S0140-6736(03)14285-7.
3
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
J Hypertens. 2002 Jul;20(7):1445-50. doi: 10.1097/00004872-200207000-00033.
4
Cardiac resynchronization in chronic heart failure.
N Engl J Med. 2002 Jun 13;346(24):1845-53. doi: 10.1056/NEJMoa013168.
5
Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.
Circulation. 2002 May 28;105(21):2512-7. doi: 10.1161/01.cir.0000017264.66561.3d.
6
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3.
7
Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.
Circulation. 2001 Jul 17;104(3):317-24. doi: 10.1161/hc2801.094031.
8
Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.
Circulation. 2001 Jul 17;104(3):286-91. doi: 10.1161/01.cir.104.3.286.
9
Hemodynamic implications of left bundle branch block.
J Electrocardiol. 2000;33 Suppl:115-21. doi: 10.1054/jelc.2000.20330.
10
The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure.
Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1853-60. doi: 10.1152/ajpheart.2001.280.4.H1853.
Zotero 插件